Skip to main content
. 2020 Jul 24;10:12385. doi: 10.1038/s41598-020-68929-9

Table 3.

Comparison of clinico-pathological features between high and low CONUT groups [Significant differences (p < 0.05)].

Clinical parameters Total
(n = 922)
CONUT > 1.0
(n = 370)
CONUT ≤ 1.0
(n = 552)
P-value
Types of operation
Pneumonectomy 29 (3.2) 17 (4.6) 12 (2.2) 0.039
Lobectomy 745 (80.8) 291 (78.6) 454 (82.3) 0.174
Bilobectomy 32 (3.5) 19 (5.1) 13 (2.4) 0.024
Segmentectomy 64 (6.9) 25 (6.8) 39 (7.0) 0.857
Wedge resection 52 (5.6) 18 (4.9) 34 (6.1) 0.404
VATS 789 (85.6) 289 (78.1) 500 (90.6) < 0.001
Postoperative findings
p-stage < 0.001
 I 665 (72.1) 230 (62.1) 435 (78.8)
 II/III 257 (27.8) 140 (37.8)** 117 (62.1)††
Adenocarcinoma 715 (77.5) 248 (67.0) 467 (84.6) < 0.001
PPC predictors
CONUT score 1.6 ± 1.8 3.4 ± 1.7 0.5 ± 0.5
PNI 42.6 ± 5.7 46.4 ± 5.9 40.1 ± 4.0 < 0.001
GPS 1.0 ± 0.6 1.4 ± 0.6 0.8 ± 0.4 < 0.001
ARISCAT 44.1 ± 3.9 45.0 ± 4.8 43.5 ± 3.0 < 0.001

CONUT controlling nutritional status, PNI prognostic nutritional index, GPS Glasgow prognostic score, ARISCAT assessment of respiratory risk in surgical patients in Catalonia, VATS video-assisted thoracoscopic surgery.

In the II/III group, 144 (15.6%) and 13 (12.3%) patients were categorized as stage II and III, respectively.

**In the II/III group, 85 (23.0%) and 59 (14.9%) patients were categorized as stage II and III, respectively.

††In the II/III group, 59 (10.7%) and 58 (10.5%) patients were categorized as stage II and III, respectively.